Vector BioMed Expands LENTIVERSE™ Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access

Vector BioMed, a leading lentiviral vector supplier and contract vector development and manufacturing organization (CVDMO), today announced the expansion of its LENTIVERSE™ platform alongside the ...

Vector BioMed Expands LENTIVERSE(TM) Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access

The expansion of LENTIVERSE (TM) platform introduces "One Lentiviral Vector Platform, Two Paths to Advance Cures," aligning scientific rigor with transparent economics and global accessibility.